Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Alpha-Beta/MycoTox antifungal collaboration

Feb. 21, 1997

New agreement reached for Searle's Maxaquin

Feb. 20, 1997

Antifungals from Schering-Plough

Feb. 20, 1997

U.S. researchers prepare chloroquine analogues

Feb. 19, 1997

Magainin lead product licensed to SKB

Feb. 17, 1997

Vaginal antifungal product cleared by FDA

Feb. 17, 1997

Neuraminidase inhibitor holds promise for flu

Feb. 14, 1997

Milestone achieved in Microcide/Pfizer collaboration

Feb. 10, 1997

Antifungal agent revealed by Bayer

Feb. 10, 1997

Japanese researchers describe triazole antifungals

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...